Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification
Genenta Science received a Nasdaq notification on October 16, 2026 that its ADSs fell below the $1.00 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The ADSs continue to trade and are not immediately delisted; the company has 180 days, until April 14, 2027, to regain compliance by closing at $1.00 or higher for 10 consecutive business days.
Key figures
- Compliance deadline
- April 14, 2027
- Compliance period days
- 180
- Bid price deficiency threshold
- $1.00
- Potential reverse split ratios
- ["1-for-10","1-for-20"]
- Consecutive days below threshold
- 30
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.